161 results
Page 4 of 9
8-K
EX-99.1
d2ltr
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
424B4
bw6 idhqb7rhh9
5 Jul 22
Prospectus supplement with pricing info
4:26pm
8-K
EX-10.1
3a83dgsgks97 0j
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
xq36rkdk7t2j
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-1.1
jk9hh ixj
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-5.1
r8u8j czi11bafdqu4
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
wiit6o
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-3.2
wlu82ff5l1b84hhuzm
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.3
0518fp9h350xx
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-3.1
6p0464vqt58siq997
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm